NCT05260151View on ClinicalTrials.gov

Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases

UnknownOBSERVATIONAL
Enrollment

155

Participants

Timeline

Start Date

November 18, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Alzheimer DiseaseProgressive Supranuclear PalsyFrontotemporal Dementia
Trial Locations (1)

100053

RECRUITING

Xuanwu Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

XINGIMAGING LLC

UNKNOWN

collaborator

H. Lundbeck A/S

INDUSTRY

collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Biogen

INDUSTRY

collaborator

Hangzhou G-Bio Biotechnology Co., Ltd

UNKNOWN

lead

Xuanwu Hospital, Beijing

OTHER